Biotech ETF Market Vectors (BBH) 122.45 $BBH
Gilead, Amgen Q4 Earnings And Weak Outlook Affect Biotech ETFs
Zacks Funds - Seeking Alpha - Fri Feb 06, 6:17AM CST
The biotech sector stood out last year and the NASDAQ Biotechnology Index delivered a stellar 34% return for 2014. Despite some temporary glitches and rough trading in between, encouraging industry trends, increasing merger and acquisition...
PBE: 52.78 (+0.30), BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), ALXN: 182.29 (+6.02), BBH: 122.45 (+0.86), IBB: 323.46 (+3.04), AMGN: 153.48 (+0.30)
Gilead, Amgen Q4 Earnings & Weak Outlook Affect Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 1:01AM CST
Concerns about pricing pressure are weighing on the overall performance of the biotech sector putting these ETFs in focus.
PBE: 52.78 (+0.30), BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), ALXN: 182.29 (+6.02), BBH: 122.45 (+0.86), IBB: 323.46 (+3.04), AMGN: 153.48 (+0.30)
Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), BBC: 28.98 (+0.18), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)
Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), BBC: 28.98 (+0.18), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)
ALPS will launch a medical breakthroughs ETF tomorrow
Seeking Alpha - at Seeking Alpha - Tue Dec 30, 12:49PM CST
BBP: 28.36 (+0.12), PBE: 52.78 (+0.30), BBC: 28.98 (+0.18), SBIO: 27.28 (+0.14), FBT: 110.21 (+1.02), XBI: 203.40 (+1.36), BBH: 122.45 (+0.86)
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 84.90 (+0.40), GILD: 101.90 (+1.10), FBT: 110.21 (+1.02), BIB: 141.30 (+2.39), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), BBH: 122.45 (+0.86), ABBV: 58.05 (+1.00)
Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Dec 23, 11:02AM CST
Gilead shares fell more than 10 percent in Monday trading following news that AbbVie and Express Scripts signed an exclusive Hepatitis C.
PBE: 52.78 (+0.30), ESRX: 84.90 (+0.40), GILD: 101.90 (+1.10), IBB: 323.46 (+3.04), BBH: 122.45 (+0.86), ABBV: 58.05 (+1.00)
LifeSci Index Partners launches 2 new biotech ETFs
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 9:51AM CST
BBP: 28.36 (+0.12), PBE: 52.78 (+0.30), BBC: 28.98 (+0.18), FBT: 110.21 (+1.02), XBI: 203.40 (+1.36), BBH: 122.45 (+0.86)
Biotech ETFs in Focus on Cubist Takeover Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Dec 09, 1:00PM CST
The Cubist takeover by Merck was well received by investors, pushing the stock and the biotech ETFs higher.
CBST: 101.94 (+0.14), FBT: 110.21 (+1.02), MRK: 58.81 (-0.07), IBB: 323.46 (+3.04), BBH: 122.45 (+0.86)
Biotech HOLDRs Trust Shares Up 12.3% Since SmarTrend's Buy Recommendation (BBH)
Comtex SmarTrend(R) - Tue Dec 09, 9:52AM CST
SmarTrend identified an Uptrend for Biotech HOLDRs Trust (AMEX:BBH) on October 21st, 2014 at $106.06. In approximately 2 months, Biotech HOLDRs Trust has returned 12.30% as of today's recent price of $119.11.
BBH: 122.45 (+0.86)
Holiday Fever Takes Hold Of Stock Investors, But A Pullback Is Needed
Scott Martindale - Seeking Alpha - Mon Nov 24, 3:14PM CST
With warmer weather arriving to melt the early snowfall across much of the country, investors seem to be catching a severe case of holiday fever and positioning themselves for the seasonally bullish time of the year. And to give an added boost, both...
IYK: 106.66 (-0.09), IYJ: 109.15 (+0.67), XTN: 106.48 (+0.70), ACT: 285.37 (+3.71), IYH: 149.63 (+0.84), LSTR: 68.62 (-0.05), IYM: 86.13 (+0.83), HAL: 44.19 (+1.42), IYC: 142.85 (+0.77), AMGN: 153.48 (+0.30), SOXX: 95.43 (+0.67), INTC: 34.36 (+0.23), IYF: 90.01 (-0.04), UPS: 101.79 (+0.38), IYE: 46.47 (+0.95), CELG: 115.88 (+0.16), AGN: 229.49 (+1.87), IYZ: 30.91 (+0.12), SPY: 209.78 (+0.86), IDU: 113.30 (-1.71), TXN: 57.97 (+0.53), BBH: 122.45 (+0.86), IYW: 107.68 (+0.94), BHI: 64.31 (+1.93)
ETF Winners From Q3 Earnings Season
Zacks Funds - at Seeking Alpha - Tue Nov 18, 9:54PM CST
The Q3 2014 earnings season appears to be a decent one, with no big surprises or huge disappointments. This is especially true as total earnings for the S&P 500 companies that have reported so far are up 6.7% on an annual basis with a beat ratio...
BBH: 122.45 (+0.86), XLI: 57.17 (+0.26), IYT: 162.23 (+0.43)
ETF Winners from Q3 Earnings Season - ETF News And Commentary
Sweta Killa - ZACKS - Tue Nov 11, 1:00PM CST
These ETFs emerged as a winner in Q3 earnings season.
BBH: 122.45 (+0.86), XLI: 57.17 (+0.26), IYT: 162.23 (+0.43)
ARK Investments launched 2 new innovation focused ETFs today
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 11:47AM CDT
ARKQ: 20.11 (+0.24), PBE: 52.78 (+0.30), FBT: 110.21 (+1.02), ARKK: 21.45 (+0.27), XBI: 203.40 (+1.36), BBH: 122.45 (+0.86), IXN: 97.63 (+0.78), ARKW: 21.83 (+0.21), ARKG: 22.80 (+0.07), IPK: 32.15 (+0.50)
The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF
PR Newswire - Fri Oct 31, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Amgen (Nasdaq:AMGN-Free Report), Celgene (Nasdaq:CELG-Free Report), Biogen Idec (Nasdaq:BIIB-Free Report), Market Vectors Biotech ETF (AMEX:BBH-Free Report) and SPDR S&P Biotech ETF (AMEX:XBI-Free Report).
BIIB: 391.66 (-0.45), BBH: 122.45 (+0.86), AMGN: 153.48 (+0.30), CELGZ: 3.17 (-0.04)
Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Oct 30, 8:00AM CDT
After some solid biotech stock earnings, these top ranked health care ETFs could be intriguing buys.
BIIB: 391.66 (-0.45), XBI: 203.40 (+1.36), BBH: 122.45 (+0.86), AMGN: 153.48 (+0.30)
Gilead, Amgen Q4 Earnings And Weak Outlook Affect Biotech ETFs
Zacks Funds - Seeking Alpha - Fri Feb 06, 6:17AM CST
The biotech sector stood out last year and the NASDAQ Biotechnology Index delivered a stellar 34% return for 2014. Despite some temporary glitches and rough trading in between, encouraging industry trends, increasing merger and acquisition...
PBE: 52.78 (+0.30), BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), ALXN: 182.29 (+6.02), BBH: 122.45 (+0.86), IBB: 323.46 (+3.04), AMGN: 153.48 (+0.30)
Gilead, Amgen Q4 Earnings & Weak Outlook Affect Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 1:01AM CST
Concerns about pricing pressure are weighing on the overall performance of the biotech sector putting these ETFs in focus.
PBE: 52.78 (+0.30), BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), ALXN: 182.29 (+6.02), BBH: 122.45 (+0.86), IBB: 323.46 (+3.04), AMGN: 153.48 (+0.30)
Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), BBC: 28.98 (+0.18), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)
Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), BBC: 28.98 (+0.18), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)
ALPS will launch a medical breakthroughs ETF tomorrow
Seeking Alpha - at Seeking Alpha - Tue Dec 30, 12:49PM CST
BBP: 28.36 (+0.12), PBE: 52.78 (+0.30), BBC: 28.98 (+0.18), SBIO: 27.28 (+0.14), FBT: 110.21 (+1.02), XBI: 203.40 (+1.36), BBH: 122.45 (+0.86)
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 84.90 (+0.40), GILD: 101.90 (+1.10), FBT: 110.21 (+1.02), BIB: 141.30 (+2.39), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), BBH: 122.45 (+0.86), ABBV: 58.05 (+1.00)
Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Dec 23, 11:02AM CST
Gilead shares fell more than 10 percent in Monday trading following news that AbbVie and Express Scripts signed an exclusive Hepatitis C.
PBE: 52.78 (+0.30), ESRX: 84.90 (+0.40), GILD: 101.90 (+1.10), IBB: 323.46 (+3.04), BBH: 122.45 (+0.86), ABBV: 58.05 (+1.00)
LifeSci Index Partners launches 2 new biotech ETFs
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 9:51AM CST
BBP: 28.36 (+0.12), PBE: 52.78 (+0.30), BBC: 28.98 (+0.18), FBT: 110.21 (+1.02), XBI: 203.40 (+1.36), BBH: 122.45 (+0.86)
Biotech ETFs in Focus on Cubist Takeover Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Dec 09, 1:00PM CST
The Cubist takeover by Merck was well received by investors, pushing the stock and the biotech ETFs higher.
CBST: 101.94 (+0.14), FBT: 110.21 (+1.02), MRK: 58.81 (-0.07), IBB: 323.46 (+3.04), BBH: 122.45 (+0.86)
Biotech HOLDRs Trust Shares Up 12.3% Since SmarTrend's Buy Recommendation (BBH)
Comtex SmarTrend(R) - Tue Dec 09, 9:52AM CST
SmarTrend identified an Uptrend for Biotech HOLDRs Trust (AMEX:BBH) on October 21st, 2014 at $106.06. In approximately 2 months, Biotech HOLDRs Trust has returned 12.30% as of today's recent price of $119.11.
BBH: 122.45 (+0.86)
Holiday Fever Takes Hold Of Stock Investors, But A Pullback Is Needed
Scott Martindale - Seeking Alpha - Mon Nov 24, 3:14PM CST
With warmer weather arriving to melt the early snowfall across much of the country, investors seem to be catching a severe case of holiday fever and positioning themselves for the seasonally bullish time of the year. And to give an added boost, both...
IYK: 106.66 (-0.09), IYJ: 109.15 (+0.67), XTN: 106.48 (+0.70), ACT: 285.37 (+3.71), IYH: 149.63 (+0.84), LSTR: 68.62 (-0.05), IYM: 86.13 (+0.83), HAL: 44.19 (+1.42), IYC: 142.85 (+0.77), AMGN: 153.48 (+0.30), SOXX: 95.43 (+0.67), INTC: 34.36 (+0.23), IYF: 90.01 (-0.04), UPS: 101.79 (+0.38), IYE: 46.47 (+0.95), CELG: 115.88 (+0.16), AGN: 229.49 (+1.87), IYZ: 30.91 (+0.12), SPY: 209.78 (+0.86), IDU: 113.30 (-1.71), TXN: 57.97 (+0.53), BBH: 122.45 (+0.86), IYW: 107.68 (+0.94), BHI: 64.31 (+1.93)
ETF Winners From Q3 Earnings Season
Zacks Funds - at Seeking Alpha - Tue Nov 18, 9:54PM CST
The Q3 2014 earnings season appears to be a decent one, with no big surprises or huge disappointments. This is especially true as total earnings for the S&P 500 companies that have reported so far are up 6.7% on an annual basis with a beat ratio...
BBH: 122.45 (+0.86), XLI: 57.17 (+0.26), IYT: 162.23 (+0.43)
ETF Winners from Q3 Earnings Season - ETF News And Commentary
Sweta Killa - ZACKS - Tue Nov 11, 1:00PM CST
These ETFs emerged as a winner in Q3 earnings season.
BBH: 122.45 (+0.86), XLI: 57.17 (+0.26), IYT: 162.23 (+0.43)
ARK Investments launched 2 new innovation focused ETFs today
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 11:47AM CDT
ARKQ: 20.11 (+0.24), PBE: 52.78 (+0.30), FBT: 110.21 (+1.02), ARKK: 21.45 (+0.27), XBI: 203.40 (+1.36), BBH: 122.45 (+0.86), IXN: 97.63 (+0.78), ARKW: 21.83 (+0.21), ARKG: 22.80 (+0.07), IPK: 32.15 (+0.50)
The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF
PR Newswire - Fri Oct 31, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Amgen (Nasdaq:AMGN-Free Report), Celgene (Nasdaq:CELG-Free Report), Biogen Idec (Nasdaq:BIIB-Free Report), Market Vectors Biotech ETF (AMEX:BBH-Free Report) and SPDR S&P Biotech ETF (AMEX:XBI-Free Report).
BIIB: 391.66 (-0.45), BBH: 122.45 (+0.86), AMGN: 153.48 (+0.30), CELGZ: 3.17 (-0.04)
Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Oct 30, 8:00AM CDT
After some solid biotech stock earnings, these top ranked health care ETFs could be intriguing buys.
BIIB: 391.66 (-0.45), XBI: 203.40 (+1.36), BBH: 122.45 (+0.86), AMGN: 153.48 (+0.30)
